FIELD: medicine.
SUBSTANCE: what is involves is the histological examination of tissue fragments taken from the extracted lung with primary, lobar and segmental bronchi at 4-5 cm from the tumour, and in respiratory bronchial epithelium adjacent to the tumour. That is followed by describing various versions of disregeneratory changes: goblet cell hyperplasia (GCH), basal cell hyperplasia (BCH), squamous metaplasia (SM) and dysplastic (D) changes. If the bronchial epithelium adjoining the tumour shows a combination of SM with neoplasia (degree II-III D; (SM+D+)), a risk of the onset of hematogenous metastases is predicted.
EFFECT: higher prediction accuracy.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RECURRENT NON-SMALL-CELL LUNG CANCER | 2012 |
|
RU2498305C1 |
| METHOD FOR PREDICTION OF RISK OF SQUAMOUS METAPLASIA IN RESPIRATORY BRONCHIAL EPITHELIUM WITH DETECTED ISOLATED BASAL CELL HYPERPLASIA | 2012 |
|
RU2538642C2 |
| METHOD FOR PREDICTION OF RISK OF RECURRENT DISEASE OF SQUAMOUS CELL LUNG CANCER OF STAGE IIB-IIIA IN PATIENTS RECEIVING ADJUVANT POLYCHEMOTHERAPY AFTER RADICAL SURGERY | 2023 |
|
RU2815575C1 |
| METHOD FOR PREDICTION OF RISK OF HEMATOGENOUS METASTASES IN NON-SMALL-CELL LUNG CANCER PATIENTS AFTER OPERATION | 2019 |
|
RU2733160C1 |
| METHOD OF PREDICTING HEMATOGENOUS METASTASES IN INTESTINAL TYPE OF STOMACH CANCER | 2011 |
|
RU2470308C1 |
| METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
| COMBINATION THERAPY OF LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2372901C2 |
| METHOD OF COMBINED TREATMENT OF LUNG CANCER STAGE III | 2007 |
|
RU2348440C2 |
| METHOD OF COMBINED TREATMENT OF NON-SMALL CELL CANCER OF LUNG OF III STAGE | 2007 |
|
RU2340336C1 |
| METHOD FOR THERMAL CHEMORADIATION OF ADVANCED NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2548770C1 |
